Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Sep 6;9(3):e003027. doi: 10.1136/rmdopen-2023-003027

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Patients with RA initiating rituximab in the Swedish, Danish and Norwegian treatment cohorts. Proportion reaching remission at 0, 3, 6 and 12 months according to six outcome definitions. ACR, American Congress of Rheumatology; ARCTIC, Aiming for Remission in rheumatoid arthritis: a randomised trial examining the benefit of ultrasound in a Clinical TIght Control regimen; DANBIO, Danish Registry for Biologic Therapies in Rheumatology; DAS28, Disease Activity Score 28; DMARD, disease-modifying antirheumatic drug; DRB, Danish Rheumatologic Biobank; NOR-VEAC, Norwegian Very Early Arthritic Clinic; RA, rheumatoid arthritis; SDAI, Simplified Disease Activity Index; SJC28, swollen 28 joint count; SRQ, Swedish Rheumatology Quality; ULRABIT, ULtrasound in Rheumatoid Arthritis patients starting BIologic Treatment; VAS, Visual Analogue Scale.